| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/21/2004 | US6833353 Inhibiting matrix metalloprotease (MMP) production using such as tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxy-ascomycin |
| 12/21/2004 | US6833349 Therapy for skin disorders; psoriasis |
| 12/21/2004 | US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity |
| 12/21/2004 | US6833130 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 12/21/2004 | CA2317604C Matrix metalloprotease inhibitors |
| 12/21/2004 | CA2266927C Skin care compositions containing an amide and a retinoid |
| 12/16/2004 | WO2004108927A1 Laminin 5b |
| 12/16/2004 | WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell |
| 12/16/2004 | WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF |
| 12/16/2004 | WO2004108716A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 12/16/2004 | WO2004108684A1 Novel azole derivative having antifungal activity |
| 12/16/2004 | WO2004108661A1 Amidino compounds as cysteine protease inhibitors |
| 12/16/2004 | WO2004108659A1 New method for synthesizing ceramide-type compounds |
| 12/16/2004 | WO2004108146A1 Material promoting wound healing |
| 12/16/2004 | WO2004108142A2 Inhibitors of tip-1 for treatment tissue damage |
| 12/16/2004 | WO2004108139A2 Use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or cancer |
| 12/16/2004 | WO2004108133A2 Modulators of vr1 receptor |
| 12/16/2004 | WO2004108112A1 Pressure-sensitive adhesive composition for preparation for external use on skin and pressure-sensitive adhesive sheet preparation for external use on skin |
| 12/16/2004 | WO2004108106A1 D-itch & equitch ointment & lotion for animal use |
| 12/16/2004 | WO2004108064A2 Diosgenin-based composition suitable for topical application |
| 12/16/2004 | WO2004091646A3 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction |
| 12/16/2004 | WO2004091474A3 Methods for the preparation of dhea derivatives |
| 12/16/2004 | WO2004089329A3 Topical compositions comprising n-acetylamino acids or related n-acetyl compounds |
| 12/16/2004 | WO2004035740A3 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 12/16/2004 | WO2004022697A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 12/16/2004 | WO2003090684A8 Polymer compositions containing a macrocyclic triene compound |
| 12/16/2004 | WO2003090514A8 Adipocyte complement related protein zacrp14 |
| 12/16/2004 | WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency |
| 12/16/2004 | US20040254375 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254249 Nonsteroidal antiinflammatory agents |
| 12/16/2004 | US20040254248 In mouth, mucous membranes; using citric acid salt or succinic acid salt as wound healing agents |
| 12/16/2004 | US20040254245 Using extract of olive leaves; moisturizers; antiinflammatory agents; prevention of acne |
| 12/16/2004 | US20040254240 Anti-cancer nitro- and thia-fatty acids |
| 12/16/2004 | US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 12/16/2004 | US20040254222 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 12/16/2004 | US20040254216 Inhibitors of p38 |
| 12/16/2004 | US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/16/2004 | US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/16/2004 | US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants |
| 12/16/2004 | US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 12/16/2004 | US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 12/16/2004 | US20040254189 Jnk inhibitors |
| 12/16/2004 | US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects |
| 12/16/2004 | US20040254176 Hypotensive agents; cardiovascular disorders; antidiabetic agents; skin disorders;kidney disorders; headaches; vision defects; strokes; synergistic mixture of amlodipine, benazepril and hydrochlorothiazide; oral administering |
| 12/16/2004 | US20040254165 Vitiligo; skin cancer; control skin coloring |
| 12/16/2004 | US20040254149 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy |
| 12/16/2004 | US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 12/16/2004 | US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation |
| 12/16/2004 | US20040254097 treating dermatological conditions related to rosacea by topically applying a composition comprising at least one peptide copper complex to an area of affected skin |
| 12/16/2004 | US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents |
| 12/16/2004 | US20040253698 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253321 Bioactive glass comprising SiO2, Na2O, K2O, Li2O, CaO, MgO, Al2O3, P2O5, B2O3 and ZnO; free from silver, nontoxic; use in cosmetic, deodorants, medicinal products, paper hygiene |
| 12/16/2004 | US20040253318 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics |
| 12/16/2004 | US20040253282 Cosmetic and dermatological preparations containing carnitine for treating and actively preventing dry skin and other negative alterations in the physiological homeostasis of healthy skin |
| 12/16/2004 | US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 12/16/2004 | US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application |
| 12/16/2004 | US20040253269 Use of dictyotal extracts in the production of a topical composition |
| 12/16/2004 | US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253226 administering to the animals angiogenesis inhibitors comprising kallikreins such as prostate specific antigens (PSA), hydrolase enzymes homologs or fragments; prophylaxis of cancer, arthritis and vision defects |
| 12/16/2004 | US20040253220 amino acid sequences of human oxidoreductase enzymes, used for activating expression of elastin; cosmetics |
| 12/16/2004 | US20040253194 Pyrithione biocides enhanced by zinc metal ions and organic amines |
| 12/16/2004 | CA2527793A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 12/16/2004 | CA2526694A1 Amidino compounds as cysteine protease inhibitors |
| 12/15/2004 | EP1486565A1 Combination PDGF, KGF, IGF, and IGFBP for wound healing |
| 12/15/2004 | EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels |
| 12/15/2004 | EP1486494A1 N-substituted benzothiophenesulfonamide derivative |
| 12/15/2004 | EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient |
| 12/15/2004 | EP1486214A1 Botulinum toxins for treating muscle spasm |
| 12/15/2004 | EP1486213A1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis |
| 12/15/2004 | EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis |
| 12/15/2004 | EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators |
| 12/15/2004 | EP1485375A1 Pyrimidine compounds |
| 12/15/2004 | EP1485374A1 Pyrimidine compounds |
| 12/15/2004 | EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485368A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity |
| 12/15/2004 | EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485360A2 Sodium channel blockers |
| 12/15/2004 | EP1485359A2 Sodium channel blockers |
| 12/15/2004 | EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485353A1 New inhibitors of histone deacetylase |
| 12/15/2004 | EP1485347A2 Hif hydroxylase inhibitors |
| 12/15/2004 | EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 12/15/2004 | EP1485121A2 Activated protein c formulations |
| 12/15/2004 | EP1485120A1 Use of one or more natural or modified oxygen carriers, devoid of plasma and cellular membrane constituents, for externally treating open, in particular chronic wounds |
| 12/15/2004 | EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 12/15/2004 | EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
| 12/15/2004 | EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 12/15/2004 | EP1485092A1 Use of rapamycin for inhibiting of cell death |
| 12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
| 12/15/2004 | EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 12/15/2004 | EP1485087A1 (+)-2- 1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 12/15/2004 | EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/15/2004 | EP1485080A1 Use of adapalene for the treatment of dermatological disorders |
| 12/15/2004 | EP1485064A2 Method for production of phytoalexins |
| 12/15/2004 | EP1485059A1 Topical dapsone for the treatment of acne |